Mundipharma International Limited Sustainability Profile
Mundipharma International Limited, a prominent player in the global pharmaceutical industry, is headquartered in Great Britain. Founded in 1997, the company has established a strong presence in various operational regions, including Europe, Asia, and the Americas. Specialising in pain management, respiratory care, and other therapeutic areas, Mundipharma is renowned for its innovative products and commitment to improving patient outcomes. The company’s core offerings include unique formulations and delivery systems that set them apart in the market. With a focus on patient-centric solutions, Mundipharma has achieved significant milestones, including strategic partnerships and a robust pipeline of new therapies. Recognised for its dedication to quality and innovation, Mundipharma continues to strengthen its market position, making a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Mundipharma International Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mundipharma International Limited's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mundipharma International Limited's reported carbon emissions
Mundipharma International Limited, headquartered in Great Britain, currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, indicating a lack of formal commitments to address carbon emissions at this time. As there is no emissions data or reduction initiatives reported, it is unclear how Mundipharma is addressing climate change within the pharmaceutical industry context. The absence of specific targets or commitments may suggest that the company is still in the early stages of developing a comprehensive climate strategy.
How Carbon Intensive is Mundipharma International Limited's Industry?
How Carbon Intensive is Mundipharma International Limited's Location?
Mundipharma International Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Mundipharma International Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
